Skyepharma Plc (SKYEY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Sales | 0 | 0 | 115,380 | 83,280 | 78,900 |
| Cost of Goods | N/A | N/A | 36,350 | 32,230 | 33,030 |
| Gross Profit | N/A | N/A | 79,020 | 51,050 | 45,870 |
| Operating Expenses | 0 | 0 | 58,600 | 82,480 | 97,980 |
| Operating Income | N/A | N/A | 20,430 | -31,430 | -52,110 |
| Other Income | 0 | 0 | -72,550 | -16,010 | 19,270 |
| Pre-tax Income | 0 | 0 | -52,120 | -47,440 | -32,840 |
| Income Tax | N/A | N/A | 1,110 | 600 | 1,460 |
| Net Income Continuous | N/A | N/A | -293 | -48,040 | -34,464 |
| Net Income Discontinuous | N/A | N/A | 0 | -6,000 | -108,260 |
| Net Income | $N/A | $N/A | $-53,230 | $-54,050 | $-142,570 |
| EPS Basic Total Ops | N/A | N/A | -3.62 | -7.04 | -1.90 |
| EPS Basic Continuous Ops | N/A | N/A | -0.03 | -6.25 | -0.46 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | -0.78 | -1.45 |
| EPS Diluted Total Ops | N/A | N/A | -3.62 | N/A | -1.90 |
| EPS Diluted Continuous Ops | N/A | N/A | -0.03 | N/A | -0.46 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | N/A | -1.45 |
| EPS Diluted Before Non-Recurring Items | 0.29 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $N/A | $N/A | $30,440 | $-20,820 | $-37,990 |